{"id":"W4404367648","doi":"10.1016/j.ctrv.2024.102853","title":"Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer","year":2024,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"Seagen; Pfizer","keywords":"Medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Breast cancer; Oncology; Cancer; Internal medicine; Epidermal growth factor receptor; Lapatinib; Cancer research; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04098811,0.001409154,0.001909364,0.002684873,0.00254055,0.003739994,0.005825455,0.01826728,0.007065966],"category_scores_gemma":[0.09948337,0.0008215918,0.004160758,0.001799305,0.002510957,0.005661482,0.004468174,0.01601088,0.005278256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004604137,"about_ca_system_score_gemma":0.01672789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005573584,"about_ca_topic_score_gemma":0.01237237,"domain_scores_codex":[0.9620283,0.02246729,0.007425411,0.001152518,0.005074176,0.001852314],"domain_scores_gemma":[0.9091927,0.04138259,0.006516665,0.001844361,0.03393004,0.007133551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001144781,0.0001371496,0.001083406,0.004771849,0.0001220972,0.001369991,0.001678684,0.001995753,0.0008435608,0.01012866,0.7423956,0.2353588],"study_design_scores_gemma":[0.0001283871,0.00008779719,0.0009681553,0.01555683,0.0001846462,0.001299445,0.001738013,0.0008127238,0.0004432466,0.01668194,0.9619712,0.0001275445],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.002538025,0.08506217,0.0346062,0.8138598,0.02355869,0.001545663,0.0008481093,0.0007034222,0.03727796],"genre_scores_gemma":[0.0558421,0.1618784,0.2249304,0.501186,0.02305649,0.005164004,0.003893548,0.0006142126,0.02343499],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.04098811,"threshold_uncertainty_score":0.2167684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3394679420235394,"score_gpt":0.5386860887968553,"score_spread":0.1992181467733159,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}